Saratov JOURNAL of Medical and Scientific Research

Remote monitoring in patients with spondylitis

Year: 2014, volume 10 Issue: №2 Pages: 314-317
Heading: Proceedings of all-Russia week of science with international participants Article type: Original article
Authors: Akulova A.l., Gaydukova I.Z.
Organization: Saratov State Medical University
Summary:

Objective: to evaluate the adherence to therapy and treatment outcomes in patients with spondylitis (SpA) in which activity of the disease managed remotely. Material and Methods. 193 patients with axial SpA were randomized into 3 groups with the different ways of the disease activity monitoring: 96 patients were managed in free way, 26 patients visited rheumatologist every 12 weeks, 69 patients managed remotely — we called them every 4 weeks. After the first year of follow up we made 3-month break in the telephone monitoring. The data on the treatment and SpA activity (indexes BASDAI, PASS, ESR, CRP) were collected. Results. In patients managed in a free way SpA activity was severe after a year. In groups managed remotely and once in 3 month the significant reduction in the disease activity was achieved with maximal decrease in remote monitoring group. Positive PASS group 3 was found in 15 patients (57.69%, n=26), in group 2 — in 4 patients (20%, n=20), in group 1 — no patients (0%). NSAIDs intake was arbitrarily changed by 5 (19.23%, n=26), 15(75%, n=20), and 93(96.87%, n=96) patients of groups 3, 2 and 1, respectively. After a 3- month break in remote monitoring in 13 patients with initial BASDAI>4 disease activity significantly increased, in 33 patients with BASDAK4 disease activity decreased. 17 (51.5%) patients independently changed the drug intake regimen after the break in monitoring. Conclusion. Remote monitoring is associated with better adherence to therapy and the best results of treatment of patients with SpA than the other modes of observation. Remote monitoring frequency must be determined individually.

Bibliography:
1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007; 21: 1379-1390
2. Braun J, Berg R van den, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011; 70 (6): 896-904
3. Ariza-Ariza R, Hern6ndez-Cruz B, Navarro-Сотрбп V, et al. A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis. Rheumatol Int 2013; 33 (11): 2731-6. doi: 10.1007/ S00296-013-2800-6
4. Burkhart PV, Sabat E. Adherence to long-term therapies. Evidence for action. J Nurs Scholarsh 2003; 35 (3): 207
5. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62 (2): 127-132
6. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21 (12): 2286-2291
7. Maksymowych WP, Richardson R, Mallon C, et al. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 2007; 57(1): 133-139
8. Rudwaleit M, Heijde D van der, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011; 70 (1): 25-31
9. Kosheleva NA, Rebrov AP Role of education and outpatient care in optimizing the treatment of patients with chronic heart failure developed after suffering a Q-myocardial infarction. The attending physician 2010; 05. Available at http://www.lvrach.ru/2010/05/13775881// Accepted 04.2010
10. McKinstry В. The use of remote monitoring technologies in managing chronic obstructive pulmonary disease. QJM 2013; 106 (10): 883-5
11. Van Sickle D, Magzamen S, Truelove S, Morrison T. Remote monitoring of inhaled bronchodilator use and weekly feedback about asthma management: an open-group, short-term pilot study of the impact on asthma control. PLoS One 2013; 8 (2): e55335.

AttachmentSize
2014_02_314-317.pdf292.37 KB

No votes yet